Search Results - COBRA KAI study team
- Showing 1 - 1 results of 1
-
1
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines by Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Romy C. Dijkland, Marian van de Meent, Kayleigh van Dijk, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, J.H. Frederik Falkenburg, Ruben A.L. de Groen, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Birgit I. Lissenberg-Witte, Arnon P. Kater, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Debbie van Baarle, Rory D. de Vries, Tom van Meerten, Pim G.N.J. Mutsaers, Abraham Goorhuis, Inger S. Nijhof, Mette D. Hazenberg, Mirjam H.M. Heemskerk, Caroline E. Rutten, COBRA KAI study team
Published in Haematologica (2025-05-01)Get full text
Article
